Factors associated with time to prostate cancer treatment initiation during the COVID-19 pandemic
American Journal of Clinical and Experimental Urology · 2025
DOI: 10.62347/binh7737 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2025. Verfasst von Ismail Ajjawi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine New Haven, CT, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale School of Medicine New Haven, CT, USA.
- University of California, San Francisco (UCSF) San Francisco, CA, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Ajjawi, I., Smani, S., Kandala, K., Sohoni, N., Sutherland, R., Washington, S. L., Kim, I. Y., & Leapman, M. S. (2025). Factors associated with time to prostate cancer treatment initiation during the COVID-19 pandemic. American Journal of Clinical and Experimental Urology. https://doi.org/10.62347/binh7737
Vancouver
Ajjawi I, Smani S, Kandala K, Sohoni N, Sutherland R, Washington SL, et al. Factors associated with time to prostate cancer treatment initiation during the COVID-19 pandemic. American Journal of Clinical and Experimental Urology. 2025. doi:10.62347/binh7737
BibTeX
@article{Ajjawi2025,
author = {Ajjawi, Ismail and Smani, Shayan and Kandala, Keervani and Sohoni, Nishan and Sutherland, Ryan and Washington, Samuel L and Kim, Isaac Y and Leapman, Michael S},
title = {Factors associated with time to prostate cancer treatment initiation during the COVID-19 pandemic},
journal = {American Journal of Clinical and Experimental Urology},
year = {2025},
doi = {10.62347/binh7737}
}
EUVIMED